Defining the Rate Of Progression of Late onset Type 1 diabetes
Type 1 diabetes is associated with loss of insulin release, which results in high blood sugars. In children and young adults this loss of insulin is known to happen quickly. After just a couple of years of having type 1 diabetes, most of this age group will make almost no insulin. Research is trying to find new treatments to slow down and even stop this insulin loss. Those developing type 1 diabetes after 30 years of age are rarely included in these trials- despite making up nearly half of all cases of type 1 diabetes. This is because, in this age group, the rate of insulin loss is unknown. Finding out this rate and factors that effect it is an important step towards including older individuals in trials.
We also aim to test a new, simpler way of monitoring insulin loss by using a finger prick blood test. This will hopefully make it possible to conduct research from home rather than in hospital. Together, the answers to these questions aim to make it easier to develop new treatments for type 1 diabetes, as these studies could recruit many more people, using a much simpler and cheaper measure of insulin loss.
The study will recruit 164 adults aged 18 and over within 100 days of a clinical diagnosis of type 1 diabetes. We will compare the loss of insulin production of 113 participants diagnosed >30 years of age with 51 participants diagnosed 18 to 30 years of age.
Study Objectives & Outcome Measures
Primary Outcome Measure:
12 month (Mixed Meal Tolerance Test) MMTT area under the curve (AUC) C-peptide. [Time Frame: 12 months]
Rate of change of MMTT AUC C-peptide over 12 months assessed at baseline,6 and 12 months [Time Frame: 12 months]